Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Enrique Alvarez

Concepts (234)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Enrique Alvarez's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Enrique Alvarez has written about over time.
Axons, 2 publications between 2011 and 2014, average publication date February 2013. Oligoclonal Bands, 1 publications between 2014 and 2014, average publication date December 2014. Neuromyelitis Optica, 4 publications between 2012 and 2020, average publication date January 2016. Pregnancy Complications, 2 publications between 2017 and 2018, average publication date April 2018. Marijuana Smoking, 1 publications between 2018 and 2018, average publication date November 2018. Medical Marijuana, 1 publications between 2018 and 2018, average publication date November 2018. Fingolimod Hydrochloride, 6 publications between 2018 and 2020, average publication date February 2019. Rituximab, 6 publications between 2011 and 2023, average publication date February 2019. Immunologic Factors, 7 publications between 2017 and 2020, average publication date April 2019. Serum Sickness, 1 publications between 2019 and 2019, average publication date September 2019. Dimethyl Fumarate, 3 publications between 2018 and 2020, average publication date October 2019. Multiple Sclerosis, Relapsing-Remitting, 11 publications between 2013 and 2024, average publication date October 2019. Immunosuppressive Agents, 9 publications between 2015 and 2024, average publication date January 2020. Antibodies, Monoclonal, Humanized, 5 publications between 2015 and 2023, average publication date April 2020. Multiple Sclerosis, Chronic Progressive, 6 publications between 2013 and 2023, average publication date May 2020. Multiple Sclerosis, 35 publications between 2011 and 2024, average publication date June 2020. Natalizumab, 5 publications between 2018 and 2023, average publication date June 2020. Lymphocyte Depletion, 3 publications between 2019 and 2021, average publication date September 2020. Agammaglobulinemia, 2 publications between 2020 and 2023, average publication date February 2022.

To see the data from this visualization as text, click here.
Alvarez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)